ERCC2 and colorectal cancer: In comparing patients and controls, we observed increased expression of nucleotide excision repair factor, ERCC2. The gene product of ERCC2, XPD, is involved in transcription-coupled nucleotide excision repair, and increased expression has been associated with chemoresistance to cisplatin [47] and colorectal cancer [48].